Walleye Capital’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-202,154
| Closed | -$1.85M | – | 2908 |
|
|
2023
Q4 | $1.85M | Buy |
202,154
+116,782
| +137% | +$1.07M | ﹤0.01% | 671 |
|
|
2023
Q3 | $885K | Buy |
+85,372
| New | +$885K | ﹤0.01% | 925 |
|
|
2023
Q1 | – | Sell |
-145,870
| Closed | -$1.64M | – | 2575 |
|
|
2022
Q4 | $1.64M | Buy |
+145,870
| New | +$1.64M | 0.03% | 537 |
|
|
2022
Q3 | – | Sell |
-83,031
| Closed | -$701K | – | 2630 |
|
|
2022
Q2 | $701K | Buy |
+83,031
| New | +$701K | 0.02% | 807 |
|